Client Background

• Client: A leading pharmaceutical company
• Industry: Pharmaceutical
• Products and Services: Medical Devices, Pharmaceutical and Packaged Goods
• Area of Operations: Worldwide
• Number of Employees: Over 100,000

Challenge

The global pharmaceutical market is projected to grow at a compound annual growth rate of 13.74% from 2020 to 2027. To maintain its position in this fast-growing industry, a global pharmaceutical leader sought to reduce the time to market for its healthcare innovations. The company recognized that boosting its efficiency, eliminating redundancies, and launching a next-gen reporting platform could deliver greater insights and lead to improved decision-making for its global teams. Optimizing its business intelligence (BI) landscape to be faster, more systematic, and standardized was critical to achieving this objective.

Solution

Wipro studied the pharmaceutical leader’s existing BI inventory on its legacy COGNOS system. The COGNOS platform had functioned for years across multiple lines of business for enterprise and self-service reporting. Although it had supported strategic decisions, operational KPI monitoring, ad-hoc analytical reports and visual canvases, the BI system required modernization to handle the company’s future needs.

Based on strategic discussions with the client’s BI teams, Wipro proposed a robust, flexible solution to migrate the company’s platform to Tableau using SNIPE, Wipro’s next-gen BI transformation toolkit. This solution helped to simplify and standardize the COGNOS landscape by creating detailed rationalization outputs based on reports and usage data for each line of business. SNIPE’s automation capabilities to accelerate Tableau migration empowered the pharmaceutical leader to begin its transforming into an intelligent enterprise in a scalable way. Meanwhile, Wipro’s BI modernization competency center served as the backbone for the pharmaceutical leader’s migration to a future-ready BI landscape.

Business benefits

The automated metadata extraction of more than 3,000 COGNOS reports into a central repository enabled full self-service through an advanced UI, delivering a 25% increase in business productivity. Furthermore, the BI landscape became 22% leaner due to the migration to Tableau and elimination of redundant and obsolete reports on COGNOS. The Tableau transition also increased BI migration productivity by 35%, significantly reducing the leader’s time to market for its pharmaceutical innovations.